Introduction. Diarrhoeagenic Escherichia coli (DEC) are difficult to distinguish from non-pathogenic commensal E. coli using traditional culture methods. The implementation of PCR targeting specific virulence genes characteristic of the five DEC pathotypes, has improved the detection of DEC in faecal specimens from patients with symptoms of gastrointestinal disease.
Aim. Antimicrobial resistance (AMR) profiles of 660 strains of DEC isolated between 2015 and 2017 from UK travellers reporting symptoms of gastrointestinal disease were reviewed to look for evidence of emerging AMR associated with travellers’ diarrhoea.
Methodology. All isolates of DEC were sequenced, and sequence type, serotype, pathotype markers and AMR profiles were derived from the genome data.
Results. A travel history was provided for 54.1 % (357/660) of cases, of which 77.0 % (275/357) reported travel outside the UK within 7 days of onset of symptoms, and 23.0 % (82/357) reported no travel in that time frame. Of the 660 strains of DEC in this study, 265 (40.2 %) samples were identified as EAEC, 48 (7.3 %) as EIEC, 61 (9.2 %) were ETEC and 286 (43.3 %) were EPEC. EPEC caused the highest percentage of infections in children (40.6 %) whilst the highest proportion of cases reporting recent travel were infected with ETEC (86.1 %). There were 390/660 (59.0 %) isolates resistant to at least one antimicrobial on the panel tested (EIEC, 81.3 %; ETEC, n=65.6 %; EAEC, n=73.2 %; EPEC, 40.9 %) and 265/660 (40.2 %) were multidrug-resistant (EIEC, 33.3 %; ETEC, 32.8 %; EAEC, 56.2 %; EPEC, 28.0 %). Genes conferring resistance to the beta-lactams and fluroquinolones were highest in the EAEC pathotype, 56.6 and 60.7%, respectively.
Conclusions. Increasing MDR, along with resistance to the fluroquinolones and the third-generation cephalosporins, in DEC causing travellers’ diarrhoea provides further evidence for the need to restrict the use of antimicrobial agents and continuous monitoring.
ByrneL,
VanstoneGL,
PerryNT,
LaundersN,
AdakGK et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. J Med Microbiol2014; 63:1181–1188 [View Article][PubMed]
JenkinsC,
LawsonAJ,
CheastyT,
WillshawGA.
Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli
. J Med Microbiol2012; 61:1082–1085 [View Article][PubMed]
DayM,
DoumithM,
JenkinsC,
DallmanTJ,
HopkinsKL et al. Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015. J Antimicrob Chemother2017; 72:145–152 [View Article][PubMed]
Do NascimentoV,
DayMR,
DoumithM,
HopkinsKL,
WoodfordN et al. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16. J Antimicrob Chemother2017; 72:3288–3297 [View Article][PubMed]
NeuertS,
NairS,
DayMR,
DoumithM,
AshtonPM et al. Prediction of phenotypic antimicrobial resistance profiles from whole genome sequences of non-typhoidal Salmonella enterica
. Front Microbiol2018; 9:592
ChattawayMA,
DallmanTJ,
GentleA,
WrightMJ,
LongSE et al. Whole genome sequencing for public health surveillance of Shiga toxin-producing Escherichia coli other than serogroup O157. Front Microbiol2016; 7:258 [View Article]
WilsonA,
EvansJ,
ChartH,
CheastyT,
WheelerJG et al. Characterisation of strains of enteroaggregative Escherichia coli isolated during the infectious intestinal disease study in England. Eur J Epidemiol2001; 17:1125–1130 [View Article]
JenkinsC,
SmithHR,
LawsonAJ,
WillshawGA,
CheastyT et al. Serotypes, intimin subtypes, and antimicrobial resistance patterns of atypical enteropathogenic Escherichia coli isolated in England from 1993 to 1996. Eur J Clin Microbiol Infect Dis2006; 25:19–24 [View Article]
SakkejhaH,
ByrneL,
LawsonAJ,
JenkinsC.
An update on the microbiology and epidemiology of enteropathogenic Escherichia coli in England 2010–2012. J Med Microbiol2013; 62:1531–1534 [View Article]
EllisSJ,
CrossmanLC,
McGrathCJ,
ChattawayMA,
HölkenJM et al. Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease. Sci Rep2020; 10:7475 [View Article]
KoutsoumanisK,
AllendeA,
Alvarez‐OrdóñezA,
Bover‐CidS,
ChemalyM et al. Pathogenicity assessment of Shiga toxin‐producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC. EFSA Journal2020; 18:e05967
JenkinsC,
LawsonAJ,
CheastyT,
WillshawGA,
WrightP et al. Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. Mol Cell Probes2003; 17:149–156 [View Article]
OchoaTJ,
RuizJ,
MolinaM,
Del ValleLJ,
VargasM,
LanataCF,
EckerL et al. High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am J Trop Med Hyg2009; 81:296–301 [View Article][PubMed]
OundoJO,
KariukiSM,
BogaHI,
MuliFW,
IijimaY.
High Incidence of Enteroaggregative Escherichia coli Among Food Handlers in Three Areas of Kenya: A Possible Transmission Route of Travelers’ Diarrhea. J Travel Med2008; 15:31–38 [View Article]
LübbertC,
StraubeL,
SteinC,
MakarewiczO,
SchubertS et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol2015; 305:148e56148–156 [View Article]
ReulandEA,
SonderGJB,
StolteI,
al NaiemiN,
KoekA et al. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae —a prospective cohort study. Clin Microbiol Infect2016; 22:731.e1-7731.e1–73731 [View Article]
von WintersdorffCJH,
PendersJ,
StobberinghEE,
Oude LashofAML,
HoebeCJPA et al. High rates of antimicrobial drug resistance gene acquisition after international travel, the Netherlands. Emerg Infect Dis2014; 20:649–657 [View Article][PubMed]